VITR — Vitrolife AB Cashflow Statement
0.000.00%
Last trade - 00:00
- SEK25.70bn
- SEK26.93bn
- SEK3.51bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 493 | 366 | 460 | 537 | -3,712 |
Depreciation | |||||
Non-Cash Items | 96.4 | 7.71 | -30.8 | 80 | 4,376 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -176 | -102 | -154 | -377 | -332 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 413 | 356 | 384 | 636 | 757 |
Capital Expenditures | -87.1 | -20.1 | -62.4 | -87 | -119 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -25.5 | -0.132 | -6,456 | -57 | -5 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -113 | -20.2 | -6,518 | -144 | -124 |
Financing Cash Flow Items | — | -10.8 | -33 | 7 | -1 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -107 | -26.6 | 5,749 | -582 | -300 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 199 | 284 | -343 | -51 | 283 |